1932

Abstract

Abstract

Preimplantation genetic diagnosis (PGD) permits the selection of embryos of a particular genotype prior to implantation. As a reproductive technology involving embryo selection, PGD has become associated with considerable controversy. This review examines some of the ethical, legal, and social issues raised by PGD. Relevant ethical considerations include the status of the embryo and the interests and duties of the parents. On a social policy level, considerations of access as well as the impact of this technology on families, women, and physician's duties also warrant consideration. An analysis of these issues in the context of using PGD for selecting embryos unaffected by a serious disorder and for sex selection is presented. We also present a brief survey of PGD-related regulatory schemes in several countries, including the United Kingdom and the United States.

Keyword(s): ELSIethicspolicyregulation
Loading

Article metrics loading...

/content/journals/10.1146/annurev.genom.7.080505.115753
2006-09-22
2024-04-17
Loading full text...

Full text loading...

/content/journals/10.1146/annurev.genom.7.080505.115753
Loading
/content/journals/10.1146/annurev.genom.7.080505.115753
Loading

Data & Media loading...

  • Article Type: Review Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error